Dimethylformamide → 5-Methoxy-3-methyl-1-(3-methyl-3-nitro-butyl)-1,3-dihydro-benzimidazol-2-one

HRID 33392Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 33392
[H-].[Na+].[CH3:3][O:4][C:5]1[CH:15]=[CH:14][C:8]2[N:9]([CH3:13])[C:10](=[O:12])[NH:11][C:7]=2[CH:6]=1.ICC[CH2:19][C:20]([CH3:25])([N+:22]([O-:24])=[O:23])[CH3:21].[CH3:26]N(C=O)C>O>[CH3:3][O:4][C:5]1[CH:15]=[CH:14][C:8]2[N:9]([CH2:13][CH2:19][C:20]([CH3:25])([N+:22]([O-:24])=[O:23])[CH3:21])[C:10](=[O:12])[N:11]([CH3:26])[C:7]=2[CH:6]=1

Komponenten

6

Versuchsvorschrift

1.1 g (28 mmol) 60% sodium hydride are added to 2.5 g (14 mmol) 5-methoxy-1-methyl-1,3-dihydro-benzimidazol-2-one in 30 mL DMF while being cooled with the ice bath. After 30 minutes a solution of 1-iodo-4-methyl-4-nitro-pentane in 20 mL DMF is piped in and the mixture is stirred overnight. It is diluted with water and extracted with ethyl acetate. The combined organic phases are washed with water, dried and evaporated down. The solid remaining is stirred with diethyl ether.

Aufarbeitung

  1. extractionextracted with ethyl acetate
  2. washThe combined organic phases are washed with water
  3. customdried
  4. customevaporated down
  5. stirringThe solid remaining is stirred with diethyl ether

Quellen und Nachweise

ORD-Eintrag
ord-d35fe270f68d4d36ba671ea26580a9ec
Quelldatensatz
uspto-grants-2008_09
Patentnummer
US07429583B2

Notizen zur Reaktion

Wird geladen…